Is Kenvue Underperforming the Nasdaq?

Kenvue Inc., a global consumer health company headquartered in Summit, New Jersey, operates in personal care, skincare, oral care, and over-the-counter health categories, spanning various countries. The company's market capitalization stands at around $34.1 billion, placing it within the large-cap stock classification. Kenvue's success is attributed to its trusted consumer health brands, promising momentum in Skin Health and Beauty, strong gross margins, extensive international presence, and positive growth in China.

However, the stock has experienced a decline of 11.7% from its 52-week high of $20.13, set on July 7, 2026. Over the last three months, Kenvue shares have decreased by 1.6%, trailing the Nasdaq Composite ($NASX), which has increased by 2% over the same period.